Cross-talk between the proto-oncogenes Met and Ron

A. Follenzi, S. Bakovic, P. Gual, M. C. Stella, P. Longati, P. M. Comoglio

Research output: Contribution to journalArticle

141 Citations (Scopus)

Abstract

Scatter Factors control a complex genetic program known as 'invasive growth'. HGF (Scatter factor 1) and MSP (Scatter Factor 2) bind to tyrosine kinase receptors encoded by the proto-oncogenes MET and RON. Using the appropriate 'kinase inactive' mutant receptors, we show that ligand-induced activation of Met results in transphosphorylation of Ron, and vice versa. Transphosphorylation is direct, as it occurs in Met or Ron receptors lacking the docking sites for signal transducers. Phosphate groups are transferred to the tyrosine phosphorylation sites responsible both for kinase up-regulation (Met: Y1234/Y1235 and Ron: Y1238/Y1239) and for generation of signal transducer docking sites (Met: Y1349/Y1356 and Ron Y1353/Y1360). The transphosphorylation specifically takes place for the receptor subfamily, as it is not observed between Met or Ron and ErbB1, ErbB2 or TrkA. Cross-linking experiments show that non-covalent Met-Ron complexes are present on the cell surface, before ligand-induced dimerization. Co-expression of a kinase inactive Ron receptor with naturally-occurring oncogenic Met mutants suppresses the transforming phenotype, suggesting a dominant negative role for the inefficient kinase partner. These data show that, while specific for their ligands, scatter factor receptors cross-talk and cooperate in intracellular signaling.

Original languageEnglish
Pages (from-to)3041-3049
Number of pages9
JournalOncogene
Volume19
Issue number27
Publication statusPublished - Jun 22 2000

Fingerprint

Proto-Oncogenes
Phosphotransferases
Proto-Oncogene Proteins c-met
Hepatocyte Growth Factor
Ligands
Transducers
Receptor Cross-Talk
Merozoite Surface Protein 1
Dimerization
Tyrosine
Up-Regulation
Phosphates
Phosphorylation
Phenotype
Growth

Keywords

  • Cross talk
  • Met
  • Ron
  • Scatter factors
  • Tyrosine kinase

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Follenzi, A., Bakovic, S., Gual, P., Stella, M. C., Longati, P., & Comoglio, P. M. (2000). Cross-talk between the proto-oncogenes Met and Ron. Oncogene, 19(27), 3041-3049.

Cross-talk between the proto-oncogenes Met and Ron. / Follenzi, A.; Bakovic, S.; Gual, P.; Stella, M. C.; Longati, P.; Comoglio, P. M.

In: Oncogene, Vol. 19, No. 27, 22.06.2000, p. 3041-3049.

Research output: Contribution to journalArticle

Follenzi, A, Bakovic, S, Gual, P, Stella, MC, Longati, P & Comoglio, PM 2000, 'Cross-talk between the proto-oncogenes Met and Ron', Oncogene, vol. 19, no. 27, pp. 3041-3049.
Follenzi A, Bakovic S, Gual P, Stella MC, Longati P, Comoglio PM. Cross-talk between the proto-oncogenes Met and Ron. Oncogene. 2000 Jun 22;19(27):3041-3049.
Follenzi, A. ; Bakovic, S. ; Gual, P. ; Stella, M. C. ; Longati, P. ; Comoglio, P. M. / Cross-talk between the proto-oncogenes Met and Ron. In: Oncogene. 2000 ; Vol. 19, No. 27. pp. 3041-3049.
@article{20c4f1f4fd3c41c989bb3f3f419c9d02,
title = "Cross-talk between the proto-oncogenes Met and Ron",
abstract = "Scatter Factors control a complex genetic program known as 'invasive growth'. HGF (Scatter factor 1) and MSP (Scatter Factor 2) bind to tyrosine kinase receptors encoded by the proto-oncogenes MET and RON. Using the appropriate 'kinase inactive' mutant receptors, we show that ligand-induced activation of Met results in transphosphorylation of Ron, and vice versa. Transphosphorylation is direct, as it occurs in Met or Ron receptors lacking the docking sites for signal transducers. Phosphate groups are transferred to the tyrosine phosphorylation sites responsible both for kinase up-regulation (Met: Y1234/Y1235 and Ron: Y1238/Y1239) and for generation of signal transducer docking sites (Met: Y1349/Y1356 and Ron Y1353/Y1360). The transphosphorylation specifically takes place for the receptor subfamily, as it is not observed between Met or Ron and ErbB1, ErbB2 or TrkA. Cross-linking experiments show that non-covalent Met-Ron complexes are present on the cell surface, before ligand-induced dimerization. Co-expression of a kinase inactive Ron receptor with naturally-occurring oncogenic Met mutants suppresses the transforming phenotype, suggesting a dominant negative role for the inefficient kinase partner. These data show that, while specific for their ligands, scatter factor receptors cross-talk and cooperate in intracellular signaling.",
keywords = "Cross talk, Met, Ron, Scatter factors, Tyrosine kinase",
author = "A. Follenzi and S. Bakovic and P. Gual and Stella, {M. C.} and P. Longati and Comoglio, {P. M.}",
year = "2000",
month = "6",
day = "22",
language = "English",
volume = "19",
pages = "3041--3049",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "27",

}

TY - JOUR

T1 - Cross-talk between the proto-oncogenes Met and Ron

AU - Follenzi, A.

AU - Bakovic, S.

AU - Gual, P.

AU - Stella, M. C.

AU - Longati, P.

AU - Comoglio, P. M.

PY - 2000/6/22

Y1 - 2000/6/22

N2 - Scatter Factors control a complex genetic program known as 'invasive growth'. HGF (Scatter factor 1) and MSP (Scatter Factor 2) bind to tyrosine kinase receptors encoded by the proto-oncogenes MET and RON. Using the appropriate 'kinase inactive' mutant receptors, we show that ligand-induced activation of Met results in transphosphorylation of Ron, and vice versa. Transphosphorylation is direct, as it occurs in Met or Ron receptors lacking the docking sites for signal transducers. Phosphate groups are transferred to the tyrosine phosphorylation sites responsible both for kinase up-regulation (Met: Y1234/Y1235 and Ron: Y1238/Y1239) and for generation of signal transducer docking sites (Met: Y1349/Y1356 and Ron Y1353/Y1360). The transphosphorylation specifically takes place for the receptor subfamily, as it is not observed between Met or Ron and ErbB1, ErbB2 or TrkA. Cross-linking experiments show that non-covalent Met-Ron complexes are present on the cell surface, before ligand-induced dimerization. Co-expression of a kinase inactive Ron receptor with naturally-occurring oncogenic Met mutants suppresses the transforming phenotype, suggesting a dominant negative role for the inefficient kinase partner. These data show that, while specific for their ligands, scatter factor receptors cross-talk and cooperate in intracellular signaling.

AB - Scatter Factors control a complex genetic program known as 'invasive growth'. HGF (Scatter factor 1) and MSP (Scatter Factor 2) bind to tyrosine kinase receptors encoded by the proto-oncogenes MET and RON. Using the appropriate 'kinase inactive' mutant receptors, we show that ligand-induced activation of Met results in transphosphorylation of Ron, and vice versa. Transphosphorylation is direct, as it occurs in Met or Ron receptors lacking the docking sites for signal transducers. Phosphate groups are transferred to the tyrosine phosphorylation sites responsible both for kinase up-regulation (Met: Y1234/Y1235 and Ron: Y1238/Y1239) and for generation of signal transducer docking sites (Met: Y1349/Y1356 and Ron Y1353/Y1360). The transphosphorylation specifically takes place for the receptor subfamily, as it is not observed between Met or Ron and ErbB1, ErbB2 or TrkA. Cross-linking experiments show that non-covalent Met-Ron complexes are present on the cell surface, before ligand-induced dimerization. Co-expression of a kinase inactive Ron receptor with naturally-occurring oncogenic Met mutants suppresses the transforming phenotype, suggesting a dominant negative role for the inefficient kinase partner. These data show that, while specific for their ligands, scatter factor receptors cross-talk and cooperate in intracellular signaling.

KW - Cross talk

KW - Met

KW - Ron

KW - Scatter factors

KW - Tyrosine kinase

UR - http://www.scopus.com/inward/record.url?scp=0034702178&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034702178&partnerID=8YFLogxK

M3 - Article

C2 - 10871856

AN - SCOPUS:0034702178

VL - 19

SP - 3041

EP - 3049

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 27

ER -